Intervention

GSK706769

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis PatientsNCT00979771 · 2010-02-01

GSK706769 Repeat Dose StudyNCT00711386 · 2008-05-16

GSK706769 A First Time in Human Study For Males and FemalesNCT00539201 · 2007-09-01

Common conditions

Arthritis, Rheumatoid1 Healthy Subjects1 Infection, Human Immunodeficiency Virus1

Leading sponsors

GlaxoSmithKline3

Trial status mix

COMPLETED1

TERMINATED1

WITHDRAWN1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.